Berman Capital Advisors’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $1K | Sell |
28
-6
| -18% | -$214 | ﹤0.01% | 1943 |
|
|
2021
Q2 | $1K | Buy |
34
+6
| +21% | +$176 | ﹤0.01% | 1797 |
|
|
2021
Q1 | $0 | Hold |
28
| – | – | ﹤0.01% | 1883 |
|
|
2020
Q4 | $0 | Hold |
28
| – | – | ﹤0.01% | 1813 |
|
|
2020
Q3 | $0 | Hold |
28
| – | – | ﹤0.01% | 1752 |
|
|
2020
Q2 | $0 | Hold |
28
| – | – | ﹤0.01% | 1798 |
|
|
2020
Q1 | $0 | Hold |
28
| – | – | ﹤0.01% | 1636 |
|
|
2019
Q4 | $0 | Hold |
28
| – | – | ﹤0.01% | 1536 |
|
|
2019
Q3 | $0 | Hold |
28
| – | – | ﹤0.01% | 1559 |
|
|
2019
Q2 | $0 | Hold |
28
| – | – | ﹤0.01% | 1558 |
|
|
2019
Q1 | $0 | Hold |
28
| – | – | ﹤0.01% | 1461 |
|
|
2018
Q4 | $0 | Buy |
+28
| New | – | ﹤0.01% | 1248 |
|